上海卓益得机器人有限公司完成近亿元人民币Pre-A+轮融资。本轮融资由上海浦东引领区投资中心、上 海张江科技创业投资有限公司联合领投，河南省科投产业发展投资基金等机构跟投。公司将通过此次融 资，在原有人形机器人产业基础上，开辟人机共生新赛道，重点布局IP活化、情感陪伴等情绪价值服 务，深耕老年人康护等新兴社会需求场景。 ...

Core Viewpoint - Recently, Shanghai Jushen Zhichuang Venture Capital Partnership (Limited Partnership) underwent a business change, adding a new partner, Xinian Equity Investment (Hangzhou) Co., Ltd., a wholly-owned subsidiary of Xinian Integrated [1] Group 1 - The company was established in April 2025 with a registered capital of 661 million yuan [1] - The business scope includes venture capital, specifically limited to investments in unlisted companies [1] - Current shareholders include Shanghai Zhangjiang Technology Venture Capital Co., Ltd. and Shanghai SAIC Chuangyuan Venture Capital Partnership (Limited Partnership), along with the newly added partner [1]

Core Insights - He Yuan Bio (688238.SH) released its Q3 2025 financial report on October 28, 2025, indicating a total of 73.72 million shares held by five institutional investors, accounting for 11.36% of the company's total share capital [1] - The institutional holding percentage decreased by 1.53 percentage points compared to the previous quarter [1] Institutional Investors - The five institutional investors include Shanghai Zhangjiang Technology Venture Capital Co., Ltd., Zhejiang Huarui Shengyin Venture Capital Co., Ltd., Shanghai Tanying Investment Partnership (Limited Partnership), Shanghai Zhangjiang Torch Venture Capital Co., Ltd., and Shanghai Ouli Investment Management Center (Limited Partnership) [1] - The total institutional holding percentage stands at 11.36% [1] Public Funds - In this period, 67 public funds were not disclosed compared to the previous quarter, including notable funds such as Huatai-PB CSI Precision Medical Index (LOF) A, SSE Composite Index ETF, Guotai SSE Comprehensive ETF, and others [1]

Core Insights - A new company, Shanghai Zhang Keton Intelligent Entrepreneurship Incubator Management Co., Ltd., has been established with a registered capital of 20 million yuan [1] - The legal representative of the company is Jin Hongmei, and its business scope includes entrepreneurship space services, enterprise management consulting, and artificial intelligence applications [1] - The company is jointly held by Beijing General Artificial Intelligence Research Institute's Tongzhi Artificial Intelligence Technology (Beijing) Co., Ltd. and Shanghai Zhangjiang (Group) Co., Ltd.'s wholly-owned subsidiary, Shanghai Zhangjiang Technology Entrepreneurship Investment Co., Ltd. [1] Company Overview - The newly established company focuses on providing services related to entrepreneurship and artificial intelligence [1] - The registered capital of 20 million yuan indicates a significant investment in the entrepreneurial ecosystem [1] - The involvement of established entities like Beijing General Artificial Intelligence Research Institute suggests a strong backing and potential for innovation in the AI sector [1] Industry Implications - The establishment of this incubator reflects the growing trend of investment in artificial intelligence and entrepreneurship in China [1] - The focus on AI applications and services aligns with the broader industry shift towards integrating advanced technologies in business operations [1] - The collaboration between research institutes and investment firms may enhance the development of AI solutions and support startups in the technology sector [1]

新华财经上海5月21日电（记者杨溢仁）科技创新与金融资本的深度融合，已成为驱动高质量发展的核 心引擎。债券市场的"科技板"应运而生。近段时间以来，科技创新债券发行节奏快速提升，以股权投资 机构为代表的发行主体正持续跑步入场。 科创债发行升温 债券市场"科技板"主要支持金融机构、科技型企业、股权投资机构这三类主体发行科技创新债券（简称 科创债）。 公开数据显示，从2025年5月6日到5月15日，共计有85支、合计规模约1358亿元的科创债（含科创票 据）密集发行，这些科创债及科创票据的发行主体涉及新材料、信息技术、金融（银行和证券）、生物 医药等行业的央国企和民企，发行期限以中长期居多，超60支达到3年和5年期及以上；已发行完毕的科 创债呈现出三大特点，即票面利率较低、认购倍数较高，普遍年利率在2%区间。 "作为股权投资机构，我们利用科创债获取的低成本、长周期资金，已投资超过20个直投项目及国家中 小企业发展基金和海望引领母基金，主要投向集成电路、人工智能、生物医药、智能制造等国家核心前 沿科创领域，为科技企业提供稳定的资本保障。"上海浦东科创集团有限公司相关负责人告诉记者，"科 创债的发行将提高科技创新公司在 ...